NO308607B1 - Kjemisk forbindelse, et farmasøytisk preparat inneholdende denne, samt anvendelse av forbindelsen til fremstilling av en blodplateaggregeringsinhibiotor og fremstilling av et farmasøytisk preparat til behandling eller forebygging av trombotiske - Google Patents
Kjemisk forbindelse, et farmasøytisk preparat inneholdende denne, samt anvendelse av forbindelsen til fremstilling av en blodplateaggregeringsinhibiotor og fremstilling av et farmasøytisk preparat til behandling eller forebygging av trombotiskeInfo
- Publication number
- NO308607B1 NO308607B1 NO944371A NO944371A NO308607B1 NO 308607 B1 NO308607 B1 NO 308607B1 NO 944371 A NO944371 A NO 944371A NO 944371 A NO944371 A NO 944371A NO 308607 B1 NO308607 B1 NO 308607B1
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmaceutical composition
- compound
- platelet aggregation
- thrombotic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/16—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5746393 | 1993-03-17 | ||
JP8214593 | 1993-04-08 | ||
JP26527393 | 1993-10-22 | ||
PCT/JP1994/000437 WO1994021599A1 (en) | 1993-03-17 | 1994-03-17 | Novel compound with platelet aggregation inhibitor activity |
Publications (3)
Publication Number | Publication Date |
---|---|
NO944371D0 NO944371D0 (no) | 1994-11-16 |
NO944371L NO944371L (no) | 1995-01-13 |
NO308607B1 true NO308607B1 (no) | 2000-10-02 |
Family
ID=27296266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO944371A NO308607B1 (no) | 1993-03-17 | 1994-11-16 | Kjemisk forbindelse, et farmasøytisk preparat inneholdende denne, samt anvendelse av forbindelsen til fremstilling av en blodplateaggregeringsinhibiotor og fremstilling av et farmasøytisk preparat til behandling eller forebygging av trombotiske |
Country Status (15)
Country | Link |
---|---|
US (2) | US5594004A (no) |
EP (1) | EP0641770B1 (no) |
JP (1) | JP2680196B2 (no) |
KR (1) | KR100196563B1 (no) |
CN (1) | CN1045084C (no) |
AT (1) | ATE166047T1 (no) |
AU (1) | AU688756B2 (no) |
CA (1) | CA2136007C (no) |
DE (1) | DE69410193T2 (no) |
DK (1) | DK0641770T3 (no) |
ES (1) | ES2117264T3 (no) |
NO (1) | NO308607B1 (no) |
NZ (1) | NZ262768A (no) |
TW (1) | TW269687B (no) |
WO (1) | WO1994021599A1 (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0656348B1 (de) * | 1993-12-03 | 2000-05-03 | F. Hoffmann-La Roche Ag | Essigsäurederivate als Arzneimittel |
WO1997036887A1 (fr) * | 1996-03-29 | 1997-10-09 | Meiji Seika Kaisha, Ltd. | Nouveaux composes heterocycliques ayant un effet d'inhibition de l'agregation des plaquettes |
US5792761A (en) * | 1996-08-12 | 1998-08-11 | Merck & Co., Inc. | Thrombin inhibitors |
EP1209152A4 (en) | 1999-08-05 | 2003-03-12 | Meiji Seika Kaisha | OMEGA-AMINO-ALPHA-HYDROXY-CARBONIC ACID DERIVATIVES WITH AN INTEGRIN ALPHA V BETA ANTAGONISM |
TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
PL206138B1 (pl) | 2000-12-25 | 2010-07-30 | Daiichi Sankyo Company Limiteddaiichi Sankyo Company Limited | Kompozycja farmaceutyczna zawierająca aspirynę oraz zestaw i zastosowanie składników kompozycji |
WO2003000657A1 (fr) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
US20070189970A1 (en) * | 2004-02-25 | 2007-08-16 | Astellas Pharma Inc. | Contrast medium for thrombus formation |
EP1778243B1 (en) * | 2004-06-30 | 2012-10-31 | Athersys, Inc. | Substituted azepine derivatives as serotonin receptor modulators |
US20060019929A1 (en) * | 2004-07-07 | 2006-01-26 | Albert Friesen | Combination therapies employing platelet aggregation drugs |
US7459468B2 (en) * | 2004-10-28 | 2008-12-02 | Medicure International, Inc. | Aryl sulfonic pyridoxines as antiplatelet agents |
US20060094749A1 (en) * | 2004-10-28 | 2006-05-04 | Medicure International Inc. | Substituted pyridoxines as anti-platelet agents |
AU2005304220A1 (en) | 2004-10-28 | 2006-05-18 | Medicure International Inc. | Dual antiplatelet/anticoagulant pyridoxine analogs |
US9206155B2 (en) | 2011-01-31 | 2015-12-08 | Council Of Scientific & Industrial Research | Chiral 1-(4-methylphenylmethyl)-5-OXO-{N-[3-T-butoxycarbonyl-aminomethyl)]-piperidin-1-yl-pyrrolidine-2-carboxamides as inhibitors of collagen induced platelet activation and adhesion |
CN103351359B (zh) * | 2013-07-25 | 2015-02-25 | 郑桂富 | 一种3-苯甲基-5-(2-羟乙基)-4-甲基噻唑啉氯的合成方法 |
US10730886B2 (en) * | 2015-09-04 | 2020-08-04 | Shin Poong Pharmaceutical Co., Ltd. | Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8528398D0 (en) * | 1985-11-19 | 1985-12-24 | Glaxo Group Ltd | Chemical compounds |
WO1988010113A1 (en) * | 1987-06-15 | 1988-12-29 | Iraj Lalezari | Compound, composition and method for the reduction of lipids the modification of the affinity of hemoglobin for oxygen and the prevention of platelet aggregation |
US4921997A (en) * | 1988-06-15 | 1990-05-01 | Montefiore Medical Center | Method of synthesis and novel compounds for pharmaceutical uses |
US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
DE4010536A1 (de) * | 1990-04-02 | 1991-10-10 | Boehringer Mannheim Gmbh | Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure |
PH31566A (en) * | 1990-10-10 | 1998-11-03 | Schering Corp | Pyridine and pyridine n-oxide derivatives for diaryl methyl piperidines or piperazines and compositions and methods of use thereof. |
JP2503797B2 (ja) | 1991-03-11 | 1996-06-05 | 株式会社セガ・エンタープライゼス | 熱変色遊戯機 |
US5220050A (en) * | 1991-05-17 | 1993-06-15 | G. D. Searle & Co. | Peptide mimetic compounds useful as platelet aggregation inhibitors |
-
1994
- 1994-03-17 AU AU62638/94A patent/AU688756B2/en not_active Ceased
- 1994-03-17 JP JP6520876A patent/JP2680196B2/ja not_active Expired - Fee Related
- 1994-03-17 US US08/347,402 patent/US5594004A/en not_active Expired - Fee Related
- 1994-03-17 DK DK94910038.2T patent/DK0641770T3/da active
- 1994-03-17 CN CN94190209A patent/CN1045084C/zh not_active Expired - Fee Related
- 1994-03-17 EP EP94910038A patent/EP0641770B1/en not_active Expired - Lifetime
- 1994-03-17 DE DE69410193T patent/DE69410193T2/de not_active Expired - Fee Related
- 1994-03-17 AT AT94910038T patent/ATE166047T1/de not_active IP Right Cessation
- 1994-03-17 CA CA002136007A patent/CA2136007C/en not_active Expired - Fee Related
- 1994-03-17 WO PCT/JP1994/000437 patent/WO1994021599A1/ja active IP Right Grant
- 1994-03-17 NZ NZ262768A patent/NZ262768A/en unknown
- 1994-03-17 ES ES94910038T patent/ES2117264T3/es not_active Expired - Lifetime
- 1994-03-17 KR KR1019940704113A patent/KR100196563B1/ko not_active IP Right Cessation
- 1994-03-18 TW TW083102367A patent/TW269687B/zh active
- 1994-11-16 NO NO944371A patent/NO308607B1/no not_active IP Right Cessation
-
1996
- 1996-10-18 US US08/733,743 patent/US5698692A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1045084C (zh) | 1999-09-15 |
CN1107277A (zh) | 1995-08-23 |
TW269687B (no) | 1996-02-01 |
US5698692A (en) | 1997-12-16 |
EP0641770A4 (en) | 1995-06-28 |
JP2680196B2 (ja) | 1997-11-19 |
US5594004A (en) | 1997-01-14 |
EP0641770B1 (en) | 1998-05-13 |
DE69410193T2 (de) | 1998-09-03 |
AU6263894A (en) | 1994-10-11 |
CA2136007C (en) | 1999-12-14 |
KR100196563B1 (ko) | 1999-06-15 |
NO944371L (no) | 1995-01-13 |
KR950701615A (ko) | 1995-04-28 |
AU688756B2 (en) | 1998-03-19 |
WO1994021599A1 (en) | 1994-09-29 |
ATE166047T1 (de) | 1998-05-15 |
ES2117264T3 (es) | 1998-08-01 |
DK0641770T3 (da) | 1998-06-02 |
EP0641770A1 (en) | 1995-03-08 |
NO944371D0 (no) | 1994-11-16 |
NZ262768A (en) | 1997-03-24 |
CA2136007A1 (en) | 1994-09-29 |
DE69410193D1 (de) | 1998-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO308607B1 (no) | Kjemisk forbindelse, et farmasøytisk preparat inneholdende denne, samt anvendelse av forbindelsen til fremstilling av en blodplateaggregeringsinhibiotor og fremstilling av et farmasøytisk preparat til behandling eller forebygging av trombotiske | |
DK0380063T3 (da) | 1,2-Cyclohexylaminoarylamider til anvendelse som analgetika | |
NO180583C (no) | Arylsulfonamido-substituerte hydroksamsyrer, farmasöytiske preparater inneholdende forbindelsene og anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
DE69820248D1 (de) | Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben | |
DE3760532D1 (en) | Benzoûb¨thiophene and benzoûb¨furancarboxamide derivatives, processes for their preparation and therapeutical agents containing them | |
PL262105A1 (en) | The method of manufacture of new derivatives of benzimidazole | |
AU645672C (en) | Agents for preserving technical materials against insects | |
ATE321543T1 (de) | Pharmazeutische zusammensetzungen mit hydroximsäurederivaten | |
NO308302B1 (no) | Tetrahydropyranderivativer, farmasøytisk preparat inneholdende slike derivater samt anvendelse derav | |
NO303578B1 (no) | Anvendelse av 2,3-trans-disubstituerte tropanforbindelser for fremstilling av medikamenter, samt slike forbindelser og farmas°ytiske preparater som omfatter dem | |
DK166323C (da) | Griseolsyrederivater og farmaceutiske midler indeholdende disse | |
ATE172721T1 (de) | Aminosäurederivate und ihre verwendung als enkephalinase-inhibitoren | |
NO304738B1 (no) | Acylerte aminoalkanimidazoler og -triazoler, farmasoeytisk preparat inneholdende disse samt anvendelse av for bindelsene for fremstilling av farmasoeytiske preparater | |
RU94014631A (ru) | Производные 4-хиномиодигидропиридина, смесь их изомеров или отдельные изомеры и их соли | |
ITMI911853A1 (it) | Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono. | |
IL66776A (en) | 2beta-substituted-2alpha-methyl-(5r)-penam-3alpha-carboxylic acid 1,1-dioxides,their preparation and pharmaceutical compositions containing them | |
ATE160146T1 (de) | Hetero-tricyclisch-substituierte phenyl- cyclohexan-carbonsäurederivate | |
ATE182594T1 (de) | Thiazolotriazol- und thiazolodiazolderivate mit fungizider aktivität | |
NO178540C (no) | Bisfenyletanderivater, farmasöytisk preparat derav samt anvendelse | |
ES2098070T3 (es) | Derivados de piperidina con una actividad antihistaminica y antileucotrienica. | |
DK1541553T3 (da) | Indolinforbindelse samt medicinsk anvendelse deraf | |
IT1245390B (it) | Composizione farmaceutica ad attivita' antivirale | |
NO303640B1 (no) | Ny forbindelse, Leustroducsin H, farmas°ytisk preparat som omfatter den, og dens anvendelse til fremstilling av et slikt preparat | |
TH14843A (th) | สารยับยั้ง hiv โปรติเอส ที่มีประโยชน์ในการรักษา aids | |
TH15282A (th) | " อนุพันธ์ควิโนโลน และแนพธิริโดนคาร์บอกซิลิแอซิด " |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN SEPTEMBER 2003 |